Are UTIs More Common After a Hysterectomy? The Anatomy, Timeline, and Risk Numbers

Yes, urinary tract infections are more common after a hysterectomy, but the risk is not uniform. Most of the excess risk is concentrated in the first 30 to 90 days after surgery, when rates run roughly 3 to 10 times higher than in the general female population. After that window closes, the long-term increase appears modest and depends heavily on which organs were removed, whether the ovaries were preserved, and how the surgery altered the pelvic floor and bladder support. A hysterectomy alone does not doom a woman to recurrent UTIs, but it does change the local anatomy and immune environment in ways that shift the odds.

The mechanism: why removing the uterus touches the urinary tract

The bladder and urethra do not exist in isolation. They sit in a shared compartment with the uterus, vagina, and rectum, and the uterus is a structural neighbor to the bladder base. When it is removed, the relationships between these organs change.

The most important anatomical factor is the shared nerve supply. The pelvic plexus carries parasympathetic fibers to both the uterus and the bladder, and the hypogastric nerves carry sympathetic fibers to both. During a hysterectomy, these nerves are at risk of stretch, partial division, or devascularization. The result is not usually frank bladder paralysis but a subtler change in detrusor contractility and sensation. A bladder that empties less completely leaves residual urine, and residual urine is the single most reliable predictor of bacterial colonization.

In plain terms: a bladder that does not empty fully is a pond, and ponds grow bacteria.

The second mechanism is loss of mechanical support. The uterus and its ligaments contribute to the support of the bladder base and the proximal urethra. Removing them can shift the urethrovesical angle. When that angle becomes less acute, urinary flow changes, and the urethra's ability to act as a competent valve weakens. Post-void dribbling and stress incontinence both increase, and both create a damp periurethral environment that favors ascending infection.

The third mechanism is estrogen. Ovaries produce estradiol, which maintains the thickness and glycogen content of the vaginal and urethral epithelium. Glycogen feeds Lactobacillus, which produces lactic acid and keeps the local pH near 4. If the ovaries are removed (oophorectomy), estrogen falls sharply, the epithelium thins, and Lactobacillus populations decline. The pH rises, and the vagina and urethra become more hospitable to Enterobacteriaceae. This is the same mechanism that drives postmenopausal genitourinary syndrome, and it is amplified when surgery is combined with oophorectomy.

The fourth mechanism is mechanical and transient: catheterization and instrumentation. Almost every hysterectomy involves at least one catheter insertion, and many involve repeated bladder drainage in the recovery period. Each catheterization carries a small but real risk of introducing uropathogens past the urethral sphincter.

How much higher is the risk? Quantified context

The clearest data come from postoperative surveillance studies. Across large series of hysterectomies, symptomatic UTI occurs in roughly 4 to 15 percent of patients within 30 days of surgery, depending on route and whether prophylactic measures were used. The baseline 30-day UTI rate for comparable gynecologic surgery without hysterectomy is lower, and the baseline rate for age-matched women not undergoing surgery is roughly 0.5 to 1 percent per month.

That gives a useful comparison. A woman in her 40s without surgery has a monthly UTI incidence around 0.5 to 1 percent. A woman in the first 30 days after hysterectomy has an incidence of 4 to 15 percent. The excess is real, and it is concentrated.

Route matters. Vaginal hysterectomy generally produces the lowest UTI rates, often under 5 percent. Laparoscopic and robotic approaches fall in the middle. Abdominal hysterectomy, particularly open abdominal with longer catheterization, produces the highest rates, sometimes exceeding 10 percent. The difference tracks with catheter duration and operative time more than with the removal of the uterus itself.

The timeline: from surgery day to year one and beyond

The table is not a prediction for any individual, but it shows where the risk lives. The first 90 days account for the majority of the excess. After that, the curve approaches the age-matched baseline, with one exception: women who develop recurrent UTIs in the first year are more likely to continue having them.

Variations: which surgery, which patient, which risk

Not every hysterectomy carries the same urinary risk.

Total versus supracervical. Removing the cervix (total hysterectomy) shortens the vaginal canal and removes the cervical mucus plug, which some clinicians believe contributes a small barrier to ascending infection. Supracervical hysterectomy preserves the cervix and may modestly reduce postoperative urinary symptoms, though the evidence is mixed and the difference is small. The larger driver is the vaginal vault closure and its effect on vaginal pH.

Oophorectomy versus ovarian preservation. When the ovaries are removed in a premenopausal woman, estrogen falls abruptly. The urethral and vaginal epithelium thins within months, and the risk of both UTI and dyspareunia rises. Preserving at least one ovary in a premenopausal woman avoids this estrogen cliff and is one reason surgeons increasingly favor ovarian conservation when oncologically safe.

Concurrent prolapse repair. Women who undergo hysterectomy together with anterior colporrhaphy or a midurethral sling have different risk profiles. The sling can correct stress incontinence but introduces mesh and a foreign body, and mesh erosion can present as recurrent UTI. Prolapse repair that restores normal anatomy often reduces UTI frequency, while repair that overcorrects or leaves a residual post-void residual can increase it.

Diabetes and immunosuppression. A woman with type 2 diabetes and an A1c above 7.5 percent has a substantially higher postoperative UTI risk in general, and the hysterectomy amplifies it. The same applies to women on chronic immunosuppression. These are not reasons to avoid surgery, but they are reasons to plan for closer urinary surveillance in the first 90 days.

Misconceptions and a non-obvious caveat

A common misconception is that the uterus protects the bladder and that its removal directly exposes the bladder to infection. The uterus does contribute structural support, but it does not form a physical barrier against bacteria. The excess UTI risk after hysterectomy comes from voiding dysfunction, catheterization, and hormonal change, not from bacterial access created by an empty pelvic space.

A second misconception is that hysterectomy causes chronic urinary infection. That is not supported. Most women have no increase in UTI frequency beyond the first year.

The non-obvious caveat is the opposite direction of causation. Some women who undergo hysterectomy do so for conditions that are themselves associated with urinary symptoms, including large fibroids pressing on the bladder, endometriosis involving the bladder base, or pelvic organ prolapse. In those cases, surgery often improves urinary function and reduces UTI frequency. The net effect on UTI risk is therefore not uniformly negative. A woman whose preoperative residual urine was 150 mL because of a fibroid pressing on the bladder may have less residual urine and fewer UTIs after surgery.

What to actually do: practical actions

Urinary risk after hysterectomy is manageable, and most of the management is behavioral and timed to the recovery window.

• Track voiding for the first two weeks. Note frequency, stream strength, and any sense of incomplete emptying. A post-void residual above 100 mL warrants a clinician conversation.
• Do not delay voiding. Holding urine after surgery increases bladder wall tension and residual volume. Void every 2 to 3 hours during waking hours in the first month.
• Maintain generous fluid intake unless a clinician restricts it. Dilute urine and frequent voiding reduce bacterial adherence to urothelium.
• For premenopausal women facing oophorectomy, discuss ovarian preservation and, if removal is necessary, discuss local vaginal estrogen for the post-surgical period once healing allows.
• Report these red flags promptly: fever above 101°F, flank pain, rigors, vomiting, or blood in the urine. These suggest upper tract involvement or pyelonephritis rather than simple cystitis.
• Do not self-treat with leftover antibiotics. Recurrent symptoms need culture, and culture needs a clean specimen.

A table of alternatives: management choices after surgery

Limitations and the state of the evidence

The evidence base has real gaps. Most postoperative UTI data come from single-institution series and administrative databases, and definitions of UTI vary. Some studies count asymptomatic bacteriuria, some count only culture-confirmed symptomatic infection, and some rely on billing codes. That inflates apparent rates and makes cross-study comparison imprecise. The 4 to 15 percent figure should be read as an order of magnitude, not a precise estimate.

Long-term data beyond five years are sparse. The assertion that risk returns to baseline after the first year is supported by several cohort studies but not by large randomized trials, which do not exist for this question and are unlikely to be performed.

The strongest established finding is the concentration of risk in the perioperative and early postoperative window. The weakest is the claim that supracervical hysterectomy meaningfully protects against later UTI. That remains a hypothesis supported by mechanism, not by robust comparative data.

A final number-consistency note: the 4 to 15 percent 30-day figure, the 0.5 to 1 percent monthly baseline, and the 2 to 6 percent recurrent-UTI prevalence after hysterectomy describe different windows and different definitions of UTI, so they should not be added together. The correct reading is that the early window is roughly 5 to 15 times the baseline monthly rate, and the long-term rate is close to baseline for most women.